Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients

Background: Tissue plasminogen activator (tPA) has been long approved as an efficacious treatment in patients with acute ischemic stroke (AIS); however, due to some serious complications, particularly intracranial hemorrhage (ICH), many physicians are still reluctant to use it liberally. This study...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Iran J Neurol
Egile Nagusiak: Sadeghi-Hokmabadi, Elyar, Yazdchi, Mohammad, Farhoudi, Mehdi, Sadeghi, Homayoun, Taheraghdam, Aliakbar, Rikhtegar, Reza, Aliyar, Hannaneh, Mohammadi-Fallah, Sahar, Asadi, Rogayyeh, Mehdizadeh-Far, Elham, Ghaemian, Neda
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Tehran University of Medical Sciences 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6121208/
https://ncbi.nlm.nih.gov/pubmed/30186557
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak